Fourteen new derivatives of the 2-azetidinone cholesterolabsorptioninhibitors have been synthesized, and three of them were enantiomerically pure. All the new compounds were evaluated for their activity to inhibitcholesterolabsorption in rats, and most of them showed comparable effects in lowering the levels of total cholesterol in the serum.